The expression of integrin ␣V subunit on 4 melanomaderived cell lines (A2058, SK-mel-5, WM-115 and WM-266-4) was analyzed. WM-115 cells, which originate from a primary tumor, were negative, whereas all 3 metastasis-derived lines had high levels of ␣V. To study ␣V integrins in the survival of melanoma cells, we developed a novel strategy that is exempt from extracellular inhibitors of ligand binding, which can activate integrin signaling and have integrin-independent effects on apoptosis. A recombinant adenovirus was used to transfer cDNA coding for a single-chain intracellular anti-␣V integrin antibody into the melanoma cells. Anti-␣V integrin adenovirus effectively inhibited the cell surface expression of ␣V integrins. In cell culture experiments, the depletion of ␣V integrins detached cells from extracellular matrix and induced apoptosis. Moreover, it prevented WM-266-4 cells from forming tumors in severe combined immunodeficiency mice but it could not prevent the growth of tumors that were formed by ␣V-negative WM-115 cells. Our results indicate that in primary melanomas there are cells that survive without ␣V integrins, whereas during the progression of disease cells can develop a dependency on these receptors. Furthermore, the data oppose the possibility that in melanoma cells apoptosis could occur due to direct activation of caspases by ligand-free ␣V integrins on the cell surface. © 2004 Wiley-Liss, Inc.
Key words: integrin; melanoma; intracellular single-chain antibody; adenovirusThe ␣V integrin can form a heterodimeric adhesion receptor with 5 different integrin  subunits, namely, 1, 3, 5, 6 and 8. These receptors bind to various extracellular matrix proteins such as fibronectin, vitronectin and osteopontin. In adult individuals, relatively few cell types express significant amounts of ␣V, and genetic data from mouse experiments indicate that most organs develop properly even in the absence of all ␣V integrins. 1 In human melanoma, the expression of ␣V together with its partner 3 has been connected to tumor growth, disease progression and poor prognosis. 2-8 Additionally, ␣V integrins may play a role in the progression of ovarian carcinoma, cervical tumors, breast cancer and squamous cell carcinoma, 9 -13 and it has also been connected to the formation of bone metastasis in prostate cancer. 14 Based on the analysis of knockout mice, it is obvious that in vivo, most normal cell types can survive without ␣V integrins. 1 In cancer cells, the inhibition of ␣V function has been associated with apoptosis, and appropriate ligand binding may be essential for the function of ␣V integrins during cancer progression. For example, the secretion of osteopontin, a ligand for ␣V3, by melanocytes has been reported to promote antiapoptotic signaling. 15 Furthermore, after disruption of cell-matrix contacts, unbound ␣V integrins may promote apoptosis in human melanoma and human intestinal carcinoma cells. 16,17 It has also been reported that in T24-E carcinoma cells, death is stimulated by attachment to the extrac...